Completed PHASE2 INTERVENTIONAL 2-arm NCT02275468

Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4

Fu-zheng-qu-zhuo Oral Liquid Combined With Integrated Therapy Improves Renal Function in Patients of Chronic Kidney Disease Stage 3 and 4，a Randomized Placebo-Control Clinical Trial

Sponsor: Fangshan Hospital of Traditional Chinese Medicine,

Conditions Stage 3 Chronic Kidney Disease Stage 4 Chronic Kidney Disease

Interventions Fu-zheng-qu-zhuo (FZQZ) oral liquid

Updated 5 times since 2017 Last updated: Oct 23, 2014 Started: Jun 30, 2010 Primary completion: May 31, 2013 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Stage 3 Chronic Kidney Disease and Stage 4 Chronic Kidney Disease, this trial is completed. The trial is conducted by Fangshan Hospital of Traditional Chinese Medicine, and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Feb 2017 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fangshan Hospital of Traditional Chinese Medicine,
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Peking University First Hospital

Data source: Guang'anmen Hospital of China Academy of Chinese Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China